Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Dose Pharmacokinetic Study of LY2605541 in Subjects With Hepatic Impairment

NCT01751399 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01751399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01751399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Dose Pharmacokinetic Study of LY2605541 in Subjects With Hepatic Impairment
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2012
Completion date
September 30, 2013
Enrollment
35 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, healthy volunteers, hepatic insufficiency